These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14757324)

  • 1. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
    Heilig M; Zachrisson O; Thorsell A; Ehnvall A; Mottagui-Tabar S; Sjögren M; Asberg M; Ekman R; Wahlestedt C; Agren H
    J Psychiatr Res; 2004; 38(2):113-21. PubMed ID: 14757324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.
    Sjöholm LK; Melas PA; Forsell Y; Lavebratt C
    J Affect Disord; 2009 Nov; 118(1-3):124-30. PubMed ID: 19264362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma.
    Soleimani L; Oquendo MA; Sullivan GM; Mathé AA; Mann JJ
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
    Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
    Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
    Ukkola O; Kesäniemi YA
    Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population.
    Lindberg C; Koefoed P; Hansen ES; Bolwig TG; Rehfeld JF; Mellerup E; Jørgensen OS; Kessing LV; Werge T; Haugbøl S; Wang AG; Woldbye DP
    Acta Psychiatr Scand; 2006 Jan; 113(1):54-8. PubMed ID: 16390370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
    Hou C; Jia F; Liu Y; Li L
    Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively.
    Widerlöv E; Lindström LH; Wahlestedt C; Ekman R
    J Psychiatr Res; 1988; 22(1):69-79. PubMed ID: 3397912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
    Pesonen U; Koch W; Schömig A; Kastrati A
    J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.
    Domschke K; Dannlowski U; Hohoff C; Ohrmann P; Bauer J; Kugel H; Zwanzger P; Heindel W; Deckert J; Arolt V; Suslow T; Baune BT
    Eur Neuropsychopharmacol; 2010 May; 20(5):301-9. PubMed ID: 19854625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
    Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
    Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
    Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
    Gjerris A; Widerlöv E; Werdelin L; Ekman R
    J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States.
    Lappalainen J; Kranzler HR; Malison R; Price LH; Van Dyck C; Rosenheck RA; Cramer J; Southwick S; Charney D; Krystal J; Gelernter J
    Arch Gen Psychiatry; 2002 Sep; 59(9):825-31. PubMed ID: 12215082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations.
    Zhu G; Pollak L; Mottagui-Tabar S; Wahlestedt C; Taubman J; Virkkunen M; Goldman D; Heilig M
    Alcohol Clin Exp Res; 2003 Jan; 27(1):19-24. PubMed ID: 12544000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts.
    Sandberg JV; Jakobsson J; Pålsson E; Landén M; Mathé AA
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1907-15. PubMed ID: 25453484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients.
    Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM
    Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures.
    Peters J; Van Kammen DP; Gelernter J; Yao J; Shaw D
    Schizophr Res; 1990; 3(5-6):287-94. PubMed ID: 2178001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.